HealthIT Answers January 5, 2021
By Drew Ivan, Chief Product and Strategy Officer, Lyniate
In December 2020, the Food and Drug Administration approved the Pfizer/BioNTech vaccine for emergency use in the U.S., making it the fastest vaccine to be brought to market. Approval of the vaccine has come just 10 months after the first COVID-19 cases were reported in the U.S. A second vaccine, from Moderna, also recently gained FDA approval.
And so begins a new race against the novel coronavirus: vaccine management and distribution. Using lessons learned from previous public health crises, such as the H1N1 outbreak, state leaders are mapping out how they will inoculate as many people as possible, as safely and effectively as possible.
To help state leaders through this process,...